‘Extraordinary’ t-cell cancer therapy results generate excitement
16 February 2016 | By Victoria White
In one study, the engineered T-cells induced complete remission in 94% of patients with acute lymphoblastic leukaemia...
List view / Grid view
16 February 2016 | By Victoria White
In one study, the engineered T-cells induced complete remission in 94% of patients with acute lymphoblastic leukaemia...
16 February 2016 | By Victoria White
As part of the I-O RPM programme, Bristol-Myers Squibb and Dana-Farber Cancer Institute will conduct a range of early phase clinical studies...
16 February 2016 | By Victoria White
MGB Biopharma and the University of Strathclyde are to extend their existing collaboration to develop novel MGB anti-infectives...
16 February 2016 | By Victoria White
AbbVie has been announced as the latest Dementia Consortium partner, joining MRC Technology, Alzheimer’s Research UK, Astex, Eisai and Lilly...
15 February 2016 | By Victoria White
Researchers say drug discovery processes are becoming unsustainably expensive despite huge technological advances because the wrong methods are being used…
15 February 2016 | By Victoria White
Eisai and Charles River have signed a collaboration agreement which will see Charles River scientists work at Eisai’s research and development facilities in Hatfield...
15 February 2016 | By Victoria White
In addition to establishing the potential for CMV-based vaccines against Ebola virus, these results are exciting from the potential insight they give into the mechanism of protection...
12 February 2016 | By Victoria White
The latest report from the Review on Antimicrobial Resistance says that vaccines and other alternatives can play a vital role in tackling the rise of drug-resistant infections...
12 February 2016 | By Victoria White
Scientists tested nimbolide, natural extract derived from India's neem tree, against pancreatic cancer in cell lines and mice...
11 February 2016 | By Victoria White
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms...
11 February 2016 | By Victoria White
The European Society of Cardiology awarded the grants to research projects that will address areas of unmet medical need in thromboembolic disease...
10 February 2016 | By Victoria White
Regeneron has joined the Human Vaccines Project, a public-private partnership to help discover and develop new vaccines and immunotherapies...
10 February 2016 | By Victoria White
Emory University scientists have found that specific types of bacteria step forward to promote healing in injured mouse intestines...
10 February 2016 | By Victoria White
The team from University of Alberta is the first ever to find a way to bond neurons and in doing so, has given researchers a powerful new tool...
9 February 2016 | By Victoria White
The programme aims to bring together breast cancer researchers and pharmaceutical companies to pool resources and stop women dying from breast cancer by 2050...